Clinical Trial Update: Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting the completion of a study evaluating a controlled-release nifedipine and valsartan combination for essential hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Nifedipine (nifedipine)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Bayer | Conditions: Hypertension | Phase 4 | Status: COMPLETED